Skip to Content
Søk Menu
We cover

ASCO 2025 | American Society of Clinical Oncology

ASCO 2025

Andreas Koulouris

Lung Cancer: Even Small Tumor Volumes Worsen Prognosis and Increase Risk of Complications After SRS

/ Andreas Koulouris
ASCO25 Play the Video

ASCO 2024

Thorgerdur Palsdottir

The Capio Model for Prostate Cancer Diagnostics

/ Thorgerdur Palsdottir
ASCO24Prostatacancer Play the Video

Har du en idé till en artikel?

Skicka ett förslag till redaktionen.

Skicka mail
Joaquim Bellmunt

First-Line Maintenance Therapy with Avelumab Show Significantly Prolonged OS and PFS in Patients with Advanced Urothelial Cancer with Low Tumor Burden

/ Joaquim Bellmunt
ASCO24Blåscancer Play the Video
Cathy Burton

Paradigm Changes in Hodgkin’s Lymphoma Treatments

/ Cathy Burton
ASCO24Hodgkins lymfomLymfom Play the Video
Oluf Dimitri Røe

ASCO24: Very Exciting Steps for Early Diagnosis and Lung Cancer

/ Oluf Dimitri Røe
ASCO24Lungcancer Play the Video

Trastuzumab Deruxtecan Significantly Improves Progression-Free Survival in Breast Cancer Patients Previously Treated with Endocrine Therapy

/ Sofie Pohl
ASCO24
Oluf Dimitri Røe

Oluf Dimitri Røe: ASCO Is the Cradle of Oncology

/ Oluf Dimitri Røe
ASCO24 Play the Video

ASCO 2023

Stine Bakkensen Bruun

Circulating Methylated-HOXA9 Tumor DNA as a Biomarker in Recurrent Breast Cancer

/ Stine Bakkensen Bruun
ASCO23Bröstcancer Play the Video

Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Does Not Change OS

/ Lars Henrik Jensen
ASCO23Mag-tarmcancer Play the Video
Jean Bourhis

ASCO 2025: Nivolumab + chemoradiotherapy improves disease-free survival in Head and Neck Cancer

/ Jean Bourhis
ASCO25Kolorektalcancer Play the Video
Inna Markovna Chen

ASCO 2025: Chemo-Immunotherapy Combined with Stereotactic Radiation Shows Promise in Pancreatic Cancer

/ Inna Markovna Chen
ASCO25 Play the Video
Sara Tolaney

ASCO 2025: Redefining First-Line Therapy in HER2+ Breast Cancer with T-DXd and Pertuzumab

/ Sara Tolaney
ASCO25BröstcancerNBCN Play the Video

Toward a New Standard of Care: Sacituzumab and Pembrolizumab in PD-L1+ mTNBC

/ Jan Andreasen
ASCO25NBCN
Bjørn Henning Grønberg

Immunotherapy after chemoradiotherapy did not improve PFS or OS in limited stage SCLC

/ Bjørn Henning Grønberg
ASCO25 Play the Video

Outstanding Results for the Treatment of Lung Cancer

/ Tony Mok
Lungcancer Play the Video
Jeanny B. Aragon-Ching

The Landscape of Treatment for Bladder Cancer Is Changing

/ Jeanny B. Aragon-Ching
Blåscancer Play the Video
Jeanny B. Aragon-Ching

Optimal Patient Population in the JAVELIN Bladder 100-trial

/ Jeanny B. Aragon-Ching
Blåscancer Play the Video

Promising Findings for R/R Large B-Cell Lymphoma – Glofitama and Epcoritamab Show Curative Potential

/ Martin Hutchings
ASCO23B-celle lymfomEHA23Lymfom Play the Video

Exciting News for CAR T Cell Therapy to Heavily Treated Patients with Multiple Myeloma

/ Sagar Lonial
ASCO23CAR-TEHA23Myelom Play the Video
Load more
Back to top